Back to Search
Start Over
Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus
- Source :
- Annals of Internal Medicine. 163:663-672
- Publication Year :
- 2015
- Publisher :
- American College of Physicians, 2015.
-
Abstract
- In a large observational database study of add-on treatments to metformin, the addition of dipeptidyl peptidase-4 (DPP-4) inhibitors was associated with a lower risk for all-cause mortality, stroke...
- Subjects :
- Oncology
medicine.medical_specialty
endocrine system diseases
business.industry
digestive, oral, and skin physiology
nutritional and metabolic diseases
Type 2 Diabetes Mellitus
General Medicine
Type 2 diabetes
Hypoglycemia
medicine.disease
Lower risk
Metformin
Endocrinology
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
business
Stroke
Dipeptidyl peptidase-4
medicine.drug
Subjects
Details
- ISSN :
- 15393704 and 00034819
- Volume :
- 163
- Database :
- OpenAIRE
- Journal :
- Annals of Internal Medicine
- Accession number :
- edsair.doi...........ee8995c9728c7c97c05490c4dec5a787